Chiltern International Ltd. will acquire Vigiun, a full service CRO located in Sao Paulo, Brazil. Vigiun, established in 1999 by Eduardo Forleo, M.D., and Elisa Halker, BSN, has experience conducting clinical trials in a variety of therapeutic areas, including infectious disease, oncology, and respiratory. “We warmly welcome Vigiun to the Chiltern team,” stated John Vann, executive vice president, Americas. “The acquisition of Vigiun enhances Chiltern’s growing presenc...